New incident report
Incident Report Number: 2020-2265
Registrant Reference Number: 2019-CA-000062, 2019-CA-000063, 2019-CA-000064
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Human
Domestic Animal
Country: CANADA
Prov / State: ALBERTA
PMRA Registration No. 31724 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard Rid Flea Dog Shampoo Citrus Scent
PMRA Registration No. 31724 PMRA Submission No. EPA Registration No.
Product Name: Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent
Yes
Unknown
Site: Animal / Usage sur un animal domestique
No
Data Subject
Sex: Female
Age: >19 <=64 yrs / >19 <=64 ans
System
>2 hrs <=8 hrs / > 2 h < = 8 h
No
No
Non-occupational
Application
None
Skin
>15 min <=2 hrs / >15 min <=2 h
>30 min <=2 hrs / >30 min <=2 h
On 24-Jun-2019, a xyear old, female, human, of unknown weight, in unknown condition, with no known concomitant medical condition, was exposed to an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Citrus Scent (Phenothrin) and also an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent (Phenothrin) while bathing her dogs with the products. The woman wore gloves initially while bathing the dogs the first time, then removed them while bathing the dogs a second time. Approximately 1 hour later, she began to experience an intermittent hot flash feeling, dizziness and then took a shower. The clinical signs resolved approximately three hours later and the woman recovered without medical intervention. Seeking medical attention from a human physician was recommended if the clinical signs returned or if any new clinical signs developed. No further information was received in this case.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Animal's Owner
Dog / Chien
Border collie
1
Female
1
25
lbs
Skin
Unknown / Inconnu
>30 min <=2 hrs / >30 min <=2 h
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 24-Jun-2019, a 1 year old, 25 pound, intact, female, Border collie in unknown condition, with concomitant medical condition of itching, was administered an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Citrus Scent (Phenothrin) and also an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent (Phenothrin) via the topical route by the animal owner. The shampoo was left on the dog for five minutes prior to rinsing. Approximately one hour after product use the dog developed lethargy. Bathing the dog with liquid dish detergent to remove the product and continuing to monitor the clinical sign was recommended. Veterinary evaluation was also recommended if the clinical sign persisted or worsened. The dog had not been evaluated by a veterinarian, no treatment had been performed and the clinical sign continued. No further information was received in this case.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Animal's Owner
Dog / Chien
Border collie
1
Female
8
30
lbs
Skin
>15 min <=2 hrs / >15 min <=2 h
<=30 min / <=30 min
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 24-Jun-2019, an 8 year old, 30 pound, intact, female, Border collie in unknown condition, with concomitant medical conditions of pruritus, red skin and multiple hotspots, was administered an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Citrus Scent (Phenothrin) and also an unknown amount of Hartz UltraGuard Rid Flea Dog Shampoo Fresh Scent (Phenothrin) via the topical route by the animal owner. The shampoo was left on the dog for ten minutes prior to rinsing. The products were used off label as they are not intended for use on dogs with broken skin. Approximately one minute post bathing, the dog developed shaking, lethargy, and its skin felt hot to the touch. The owner then bathed the dog with liquid dish soap. Bathing the dog a second time with liquid dish soap was recommended. Veterinary evaluation was recommended if the clinical signs persisted or worsened. The dog had not been evaluated by a veterinarian, no treatment had been performed and the clinical signs continued. No further information was received in this case.
Moderate
Assessment: The active ingredient, phenothrin, is present in low concentration in this product and has a wide margin of safety in dogs. The rapid onset shaking, lethargy and warm skin may have been related to a paresthesia response. Systemic effects are not expected. The dog also had areas of damaged skin (hot spots) when the product was applied. This may have also contributed to the reported signs if the product entered those areas of broken skin causing irritation. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.